Ying Liu1, Xiangzhu Zeng1, Zheng Wang1, Na Zhang2, Dongsheng Fan2, Huishu Yuan3. 1. Department of Radiology, Peking University Third Hospital, Beijing, China. 2. Department of Neurology, Peking University Third Hospital, Beijing, China. 3. Department of Radiology, Peking University Third Hospital, Beijing, China. Electronic address: huishuy@sina.com.
Abstract
PURPOSE: To evaluate cerebral blood flow (CBF) in patients with Alzheimer's disease (AD) using a three-dimensional pseudocontinuous arterial spin labeling (PCASL). We aimed to study the effects of different post label delay on the resulting CBF maps and to investigate the characteristics and clinical applications of brain perfusion. MATERIALS AND METHODS: Sixteen AD patients and nineteen healthy control subjects were recruited. 3D PCASL was performed using a 3.0 T MR scanner. ASL was performed twice with different post label delays (PLD). Comparisons of CBF were made between AD patients and healthy control subjects respectively with PLD of 1.5 s and PLD of 2.5 s. Relationship between the CBF values and cognition was investigated using correlation analysis. A receiver operating characteristic (ROC) curve was generated for CBF measurements in posterior cingulate region. RESULT: AD patients with PLD of 1.5 s showed lower CBF values primarily in bilateral temporal lobes, precuneus, middle and posterior cingulate gyri, left inferior parietal gyrus, left angular gyrus and left superior frontal gyrus. Lowered cerebral values were also observed in similar regions with PLD of 2.5 s, but the clusters of voxel were smaller. CBF values were associated with cognition scores in most of gyri mentioned above. CONCLUSION: Hypoperfusion areas were observed in AD patients. PLD of 1.5s was sufficient to display CBF. Considering the complicated AD pathology, multiple PLDs are strongly recommended.
PURPOSE: To evaluate cerebral blood flow (CBF) in patients with Alzheimer's disease (AD) using a three-dimensional pseudocontinuous arterial spin labeling (PCASL). We aimed to study the effects of different post label delay on the resulting CBF maps and to investigate the characteristics and clinical applications of brain perfusion. MATERIALS AND METHODS: Sixteen ADpatients and nineteen healthy control subjects were recruited. 3D PCASL was performed using a 3.0 T MR scanner. ASL was performed twice with different post label delays (PLD). Comparisons of CBF were made between ADpatients and healthy control subjects respectively with PLD of 1.5 s and PLD of 2.5 s. Relationship between the CBF values and cognition was investigated using correlation analysis. A receiver operating characteristic (ROC) curve was generated for CBF measurements in posterior cingulate region. RESULT: ADpatients with PLD of 1.5 s showed lower CBF values primarily in bilateral temporal lobes, precuneus, middle and posterior cingulate gyri, left inferior parietal gyrus, left angular gyrus and left superior frontal gyrus. Lowered cerebral values were also observed in similar regions with PLD of 2.5 s, but the clusters of voxel were smaller. CBF values were associated with cognition scores in most of gyri mentioned above. CONCLUSION: Hypoperfusion areas were observed in ADpatients. PLD of 1.5s was sufficient to display CBF. Considering the complicated AD pathology, multiple PLDs are strongly recommended.
Authors: Sara Ponticorvo; Renzo Manara; Josef Pfeuffer; Arianna Cappiello; Sofia Cuoco; Maria Teresa Pellecchia; Renato Saponiero; Donato Troisi; Claudia Cassandro; Marta John; Alfonso Scarpa; Ettore Cassandro; Francesco Di Salle; Fabrizio Esposito Journal: Hum Brain Mapp Date: 2019-02-04 Impact factor: 5.038
Authors: Catherine A Morgan; Tracy R Melzer; Reece P Roberts; Kristina Wiebels; Henk J M M Mutsaerts; Meg J Spriggs; John C Dalrymple-Alford; Tim J Anderson; Nicholas J Cutfield; Gerard Deib; Josef Pfeuffer; Donna Rose Addis; Ian J Kirk; Lynette J Tippett Journal: Sci Rep Date: 2021-12-02 Impact factor: 4.379
Authors: Hai Rong Ma; Ping Lei Pan; Li Qin Sheng; Zhen Yu Dai; Gen Di Wang; Rong Luo; Jia Hui Chen; Pei Rong Xiao; Jian Guo Zhong; Hai Cun Shi Journal: Oncotarget Date: 2017-10-04